Estrategias de control glicémico y la ocurrencia de infección del sitio quirúrgico: revisión sistemática by Domingos, Caroline Maria Herrero et al.
868 Rev Esc Enferm USP · 2016;50(5):868-874 www.ee.usp.br/reeusp
Glycemic control strategies and the occurrence of surgical site infection: a systematic review
1 Universidade de São Paulo, Hospital 
Universitário, São Paulo, SP, Brazil. 
2 Universidade de São Paulo, Hospital 
Universitário, Serviço de Ensino e 
Qualidade, São Paulo, SP, Brazil. 
3 Universidade de São Paulo, Escola de 
Enfermagem, Departamento de Enfermagem 
Médico-Cirúrgica, São Paulo, SP, Brazil. 
Received: 03/03/2016
Approved: 08/30/2016
ARTICLE REVIEW DOI: http://dx.doi.org/10.1590/S0080-623420160000600022
Corresponding author:
Vanessa de Brito Poveda
Escola de Enfermagem, 
Universidade de São Paulo
Av. Doutor Enéas de Carvalho 
Aguiar, 419 – Cerqueira César
CEP 05403-000 – São Paulo, SP, Brazil
vbpoveda@usp.br
ABSTRACT
Objective: To analyze the available evidence in the scientific literature on the 
relationship between glycemic control strategies performed and the occurrence of 
surgical site infection in adult patients undergoing surgery. Method: This is a systematic 
review, through the CINAHL, Medline, LILACS, Cochrane Database of Systematic 
Reviews, and EMBASE, which included 8 studies. Results: Despite the diversity of 
tested interventions, studies agree that glycemic control is essential to reduce surgical site 
infection rates and should be kept between 80 and 120 mg/dl during the perioperative 
period. Insulin continuous infusion during surgery was the most tested and seems to 
get better results in reducing surgical site infection rates and success in glycemic control 
compared to other strategies. Conclusion: Strict glycemic control during the perioperative 
benefits the recovery of surgical patients, especially for the successful implementation of 
the measure the performance of the nursing team.
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INTRODUCTION
Healthcare-associated infections (HAIs) are a major 
cause of morbidity and mortality, and consequently of 
higher care costs. HAIs are those acquired after patient’s 
hospital admission, and manifested during hospitaliza-
tion or after discharge, when related to hospitalization or 
hospital procedures(1).
In Brazil, surgical site infections (SSI) ranks third 
among the HAIs(1). In 2013, in the state of São Paulo, 
among the 514 hospitals that performed more than 250 
clean surgeries per month such as cardiac, neurological 
and orthopedic surgery, there was a median of 0.48% 
cases of SSI(2).
SSIs are the main causes of complications among pa-
tients undergoing surgical procedures, increasing hospital 
length of stay and costs, and also causing physical and emo-
tional damage to patients(3-7).
SSIs affect the surgical wound and are classified accord-
ing to the topography. It is considered superficial incisional 
SSI (SI - SSI) if occurrence is in the first 30 days after 
surgery, and involves only skin and subcutaneous tissue; it 
is deep incisional SSI (DI – SSI) when deep soft tissues 
are affected, and occurrence within 30 days after surgery, or 
even after a year in cases of prosthetic implants; finally, it is 
organ/space SSI (OS - SSI) when identified in the first 30 
days after surgery, or even after a year, and affects organs or 
cavities manipulated during surgery(1).
In a recent recommendation, the Centers for Disease 
Control and Prevention (CDC) suggested changing the 
surveillance period of deep and organ and/or space infec-
tions for the maximum of 90 days, replacing the earlier 
recommended period of one year(4).
Some intrinsic and extrinsic factors to patients can 
be crucial for the occurrence of SSIs. They are related to 
the procedure to be performed, such as type of surgery, 
its duration, employed techniques, preoperative prepara-
tion, and factors related to inoculum of microorganisms, 
such as their virulence and resistance originating from 
the environment and the patient’s microflora. There are 
also factors related to patients themselves, as extremes of 
age, smoking, obesity, malnutrition, use of immunosup-
pressive drugs, and the presence of chronic diseases such 
as diabetes mellitus (DM) and hyperglycemia, which 
motivated this study(3-7).
In this sense, with significant improvements in quality 
of life and technological advances, combined with higher 
survival, there is increased population with chronic dis-
eases (such as diabetes mellitus) that will undergo surgi-
cal procedures. Therefore, many chronic diseases need to 
be stabilized for a successful surgical intervention, i.e., to 
minimize the occurrence of risks(3,5,7-9).
Coupled with DM, hyperglycemia is a frequent prob-
lem encountered in patients in critical condition and/
or undergoing surgical procedures. It is a cause of mor-
bidity and mortality due to physiological abnormalities 
of healing, vascular and neuropathic complications, and 
inhibition of these individuals’ defense system, making 
them more aggressively exposed to the risk of SSIs(10-11).
Hyperglycemia can be defined as the abnormal in-
crease in blood glucose levels, greater than 140 mg/dL 
in patients with no history of diabetes or absence of 
changes in glycated hemoglobin levels(10-11).
The aim of the present study was to analyze the avail-
able evidence in the scientific literature regarding the re-
lationship between glycemic control strategies used and 
the occurrence of surgical site infection in adult patients 
undergoing surgery, and identify gaps in the scientific 
knowledge produced so far to point recommendations 
for future research.
METHOD
A systematic review (SR) of literature was conducted 
with the aim to identify the studies with best method-
ological quality that can bring evidence for the improve-
ment of health care practices by assisting in decision 
making, and that are also relevant tools for scientific 
investigation(12-13).
The following steps were established to perform this 
systematic review: definition of the research question; 
search for evidence in the literature; revision and selection 
of studies according to the inclusion and exclusion criteria; 
analysis, synthesis and presentation of results(12-13).
The PICO strategy was used to elaborate the research 
question (Chart 1).
Chart 1 – PICO strategy – São Paulo, SP, Brazil, 2016.
P (patient) Adult surgical patient
I (intervention) Perioperative glycemic control
C (control) Usual care
O (outcome) Occurrence of surgical site infection
The guiding question of the systematic review was: 
What is the relationship between blood glucose control strate-
gies used perioperatively with adult surgical patients and the 
occurrence of SSI?
The following databases were used to search for the 
studies included in the systematic review: Cumulative 
Index to Nursing and Allied Health Literature 
(CINAHL); Medical Literature Analysis and Retrieval 
System Online (MEDLINE); Latin American and 
Caribbean Health Sciences (LILACS); Cochrane 
Database of Systematic Reviews (CDSR, Cochrane 
Reviews); EMBASE.
After selection of the articles included in the re-
view, was performed a careful analysis of the references 
listed in these studies to identify new references that 
may not have been located by the initial strategy or-
ganized (gray literature). Thus, to perform the search, 
the controlled and uncontrolled descriptors were com-
bined as follows (Chart 2):
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Chart 2 – Distribution of search strategies according to the database and number of articles located – São Paulo, SP, Brazil, 2016.
Database Search Retrieved articles
PUBMED
((("surgical wound infection"[MeSH Terms] OR ("surgical"[All Fields] AND "wound"[All Fields] AND 
"infection"[All Fields]) OR "surgical wound infection"[All Fields] OR ("surgical"[All Fields] AND "site"[All 
Fields] AND "infection"[All Fields]) OR "surgical site infection"[All Fields]) OR ("surgical wound 
infection"[MeSH Terms] OR ("surgical"[All Fields] AND "wound"[All Fields] AND "infection"[All Fields]) OR 
"surgical wound infection"[All Fields])) OR "Surgical Wound Infection"[Mesh]) AND (((((((("glucose"[MeSH 
Terms] OR "glucose"[All Fields]) AND ("prevention and control"[Subheading] OR ("prevention"[All Fields] 
AND "control"[All Fields]) OR "prevention and control"[All Fields] OR "control"[All Fields] OR "con-
trol groups"[MeSH Terms] OR ("control"[All Fields] AND "groups"[All Fields]) OR "control groups"[All 
Fields])) OR (("blood glucose"[MeSH Terms] OR ("blood"[All Fields] AND "glucose"[All Fields]) OR 
"blood glucose"[All Fields]) AND ("prevention and control"[Subheading] OR ("prevention"[All Fields] 
AND "control"[All Fields]) OR "prevention and control"[All Fields] OR "control"[All Fields] OR "control 
groups"[MeSH Terms] OR ("control"[All Fields] AND "groups"[All Fields]) OR "control groups"[All Fields]))) 
OR ("blood glucose"[MeSH Terms] OR ("blood"[All Fields] AND "glucose"[All Fields]) OR "blood glucose"[All 
Fields] OR ("blood"[All Fields] AND "sugar"[All Fields]) OR "blood sugar"[All Fields])) OR ("glycaemic 
index"[All Fields] OR "glycemic index"[MeSH Terms] OR ("glycemic"[All Fields] AND "index"[All Fields]) 
OR "glycemic index"[All Fields])) OR "Glycemic Index"[Mesh]) OR ("blood glucose"[MeSH Terms] OR 
("blood"[All Fields] AND "glucose"[All Fields]) OR "blood glucose"[All Fields])) OR "Blood Glucose"[Mesh]) 
AND ((Clinical Trial[ptyp] OR Clinical Trial, Phase I[ptyp] OR Clinical Trial, Phase II[ptyp] OR Clini-
cal Trial, Phase III[ptyp] OR Clinical Trial, Phase IV[ptyp] OR Review[ptyp]) AND ("adult"[MeSH Terms] 
OR "adult"[MeSH Terms:noexp] OR ("middle aged"[MeSH Terms] OR "aged"[MeSH Terms]) OR "middle 
aged"[MeSH Terms] OR "young adult"[MeSH Terms])) AND Review[ptyp]
n = 40
CINAHL
(MH "Glycemic Control") OR "glycemic control" OR "glucose control" OR (MH "Blood Glucose") OR (MH 
"Blood Glucose Monitoring") OR "blood glucose control" OR "blood sugar" OR (MH "Surgical Wound Infec-
tion") AND "surgical wound infection" OR "surgical site infection"
n = 86
LILACS "infecção da ferida operatória" [subject descriptor] AND "índice glicêmico" [subject descriptor] n = 0
EMBASE
'blood'/exp OR blood AND ('glucose'/exp OR glucose) OR 'blood'/exp OR blood AND ('sugar'/exp OR 
sugar) OR 'blood'/exp OR blood AND ('glucose'/exp OR glucose) AND ('control'/exp OR control) OR 
'glycemia'/exp OR glycemia AND index OR 'glucose'/exp OR glucose AND ('control'/exp OR control) AND 
surgical AND ('wound'/exp OR wound) AND ('infection'/exp OR infection) OR surgical AND site AND 
('infection'/exp OR infection) AND ([young adult]/lim OR [adult]/lim OR [middle aged]/lim OR [aged]/lim) 
AND [humans]/lim AND [embase]/lim
n = 501
Cochrane 'Blood Glucose' or 'Glycemia Index' or 'Blood sugar' or 'Blood glucose control' or 'Glucose control' and 'Surgical Wound Infection' or 'surgical site infection' n = 248
The systematic review included randomized con-
trolled trials that analyzed different glycemic control 
strategies in the perioperative period used with patients 
aged 18 years or over and their relationship with the 
occurrence of SSI, published in English, Spanish and 
Portuguese, from the indexing date in the investigated 
databases until December 12th, 2015.
The following articles were excluded: those on glyce-
mic control procedures in patients who did not undergo 
surgery; those testing interventions in animals or in labo-
ratory; and those using only one dietary control strategy 
for blood glucose regulation.
The extraction of data from the studies included in 
the review was performed by two reviewers indepen-
dently, using the Jadad et al. score to assess the quality of 
randomized controlled trials(14).
The synthesis of data from the studies included 
in the systematic review was performed descriptively, 
including information such as sample size, the imple-
mented and measured intervention, the statistical 
analysis adopted, and the main results. For a better un-
derstanding of results, were established categories ac-
cording to similarity of tested interventions, i.e., studies 
testing the management of blood glucose by intravenous 
insulin infusion, and studies testing the subcutaneous 
administration of insulin.
Records identied by
database search
PUBMED (n = 40);
CINAHL (n = 86);
LILACS (n = 0);
EMBASE (n = 501);
Cochrane (n = 248)
(n = 878)
Records after removing duplicates
(n = 873)Sc
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Additional records
identi ed through
other sources
(n = 04 )
Tracked records
(n = 877)
Excluded records
(n = 850)
Full text articles
evaluated for eligibility
(n = 27)
Included studies
(n = 08)
Full text articles
excluded for not being
randomized
controlled trials,
meta-analyzes or
systematic reviews, or
including non-surgical
(n = 19)patients
Figure 1 – Flowchart for selection of articles included in the re-
view - São Paulo, SP, Brazil, 2016.
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RESULTS
Eight randomized clinical trials were included in 
this review, all published in English in journals such as 
Diabetes Care (n = 2), Anesthesiology, Annals of Internal 
Medicine, Circulation, Endocrine Practice, Journal of 
Neurosurgery Anesthesiology, and Texas Heart Institute 
Journal. Most investigations were produced in the United 
States of America (USA) (n  =  4), followed by Japan 
(n = 2), Italy (n = 1) and China (n = 1).
The studies addressed different types of surgical special-
ties such as general surgery, gastrointestinal, vascular and 
heart surgery, and the study groups included diabetic and 
nondiabetic patients, with samples ranging between 41 and 
447 subjects(15-22).
Regarding methodological quality of the analyzed studies, 
their scores ranged from 1 to 3, which shows low or moderate 
methodological quality(15-22).
Table 3 presents a summary of the studies included in this 
systematic review, its main results and conclusions, according 
to the categories of intravenous insulin infusion and subcuta-
neous administration of insulin.
The category of intravenous insulin infusion included sev-
en studies that used continuous infusion of insulin, compared 
to different forms of glycemic control focused on maintaining 
the blood glucose below 200 mg/dL, preferably with values 
below 150 mg/dL, which had higher association with reduced 
rates of SSI and/or several other outcomes(15-21). Among the 
seven studies included in this category, only two(17,19) revealed 
no statistically significant associations between continuous in-
fusion of insulin and the occurrence of SSI. However, it stands 
out that both studies address the comparison of continuous 
infusion and bolus infusion of insulin (Chart 3).
According to the included studies, maintenance of gly-
cemia should be a goal during the perioperative period. 
Regarding the benefit of continuous infusion of insulin, there 
seems to be a trend of superiority in preventing SSI and other 
outcomes, but there is a wide range of tested interventions, 
different cutoff values related to glucose and diversity at the 
time of starting the intervention(15-21).
Only one study examined the glycemic control intraop-
eratively by subcutaneous regular insulin administration, and 
found that a more rigorous control of blood sugar, keeping it 
between 80 and 110 mg/dL, was associated with reduced SSI 
rates and decreased hospitalization period(22).
Note that studies included in this review emphasized the 
possible increased incidence of comorbidities postoperatively 
caused by hyperglycemia, such as dehiscence, fistulas, bacte-
remia, renal failure, urinary tract and bloodstream infections, 
and increased SSI rates(15-16,18-22).
Chart 3 – Summary of the studies included in the systematic review according to type of patient, study groups, results and conclu-
sions – São Paulo, SP, Brazil, 2016.
Intravenous administration of insulin
Study Sample Type of surgery/ patient Intervention group (IG) Control group (CG) Result/Conclusion Jadad
Li et al., 
2006(15) n = 93
Coronary bypass/
Diabetic and 
nondiabetic patients
IPO: Continuous IV 
infusion of insulin 
(n = 51)
IPO: Subcutaneous 
regular insulin by 
glucometer (n = 42)
IG was associated with 
lower SSI rates 2
Okabayashi 
et al., 2009(16) n = 88
Surgical resection 
of liver/
Diabetic patients
IPO: Continuous IV 
infusion of insulin 
(n = 44)
IPO: Tight glucose 
control by subcutaneous 
regular insulin 
administration (n = 44)
IG was associated with 
lower SSI rates and costs 1
Subramaniam 
et al., 2009(17) n = 236
Vascular surgery/
Diabetic and 
nondiabetic patients
IO: Continuous IV 
infusion of insulin to 
maintain blood glucose 
between 100 and 
150 mg/dL (n = 114)
IO: IV bolus infusion 
of insulin to maintain 
blood glucose lower 
than 150 mg/dL 
(n = 122)
IG obtained fewer 
cardiovascular effects, but 
there was no statistically 
significant difference for SSI 
between the study groups
3
Bilotta et al., 
2007(18) n = 78
Brain aneurysm 
surgery/
Diabetic patients
IO: Continuous IV 
infusion of insulin to 
maintain blood glucose 
between 80 and 
120 mg/dL (n = 40)
IO: continuous IV 
infusion of insulin to 
maintain blood glucose 
between 80 and 220 
mg/dL (n = 38)
IG was associated with 
lower rates of urinary tract 
infection, 
pneumonia and SSI
3
Gandhi et al., 
2007(19) n = 371
Cardiac surgery/
Diabetic and 
nondiabetic patients
IO: Continuous IV 
infusion of insulin to 
maintain blood glucose 
between 80 and 
100 mg/dL (n = 185)
IO: IV bolus infusion 
of insulin when blood 
glucose ≥ 200 mg/dL 
(n = 186)
There was no 
difference between the 
study groups regarding the 
occurrence of SSI, heart 
failure, kidney failure and 
death
3
Lazar et al., 
2004(20)  n= 141
Coronary artery 
bypass surgery/
Diabetic patients
IO: IV infusion of 
glucose, regular insulin 
and potassium (n = 72)
IO: IV infusion of 
glucose solution 
(n = 69)
IG was associated with 
lower rates of 
pneumonia and SSI
1
Grey et al, 
2004(21) n = 61
General surgery/
Diabetic patients
PO: Continuous IV 
infusion of insulin to 
maintain blood glucose 
between 80 and 120 
mg/dL (n = 27)
PO: Continuous IV 
infusion of insulin to 
maintain blood glucose 
between 180 and 220 
mg/dL (n = 34)
IG was associated with 
lower rates of bloodstream 
infections and SSIs
2
continued...
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Subcutaneous administration of insulin
Study Sample Type of surgery/ patient Intervention group (IG) Control group (CG) Result/Conclusion Jadad
Okabayashi 
et al., 2014(22) n = 447
Surgical resection of 
pancreas and/or liver/
Diabetic patients
IO: Tight glycemic 
control of 4.4-6.1 mmol/L 
(80-110 mg/dL) using 
subcutaneous regular 
insulin (n = 222)
IO: Glycemic control of 
7.7-10.0 mmol/L (140-
180 mg/dL) using subcu-
taneous regular insulin 
(n = 225)
IG was associated with lower 
SSI rates and decreased 
hospital length of stay
2
Legend: IO: intraoperative; IPO: immediate postoperative period; PO: postoperative; IV: intravenous; SC: subcutaneous; SSI: surgical site infection; IG: intervention group; 
CG: control group.
...continuation
DISCUSSION
Glycemic control is an important aspect in the preven-
tion of surgical site infections, and occupies position of 
equal importance among other traditional preventive mea-
sures such as appropriate antibiotic prophylaxis, normother-
mia and hair removal(23).
In addition, a recent integrative review found that 23 
out of 26 studies emphasized the need for glycemic control, 
observing an association of hyperglycemia with infections 
in the postoperative period, highlighting SSIs, increased 
morbidity, mortality, and costs during hospitalization(5).
A systematic review published in 2009 included only 
five studies and aimed to verify the relationship between 
glycemic control and the incidence of surgical site infec-
tions, mortality and length of hospital stay. It found a lack of 
evidence, demonstrating that glycemic control is sufficient 
for the prevention of SSIs, especially given the poor sam-
pling of included studies and inconsistencies in the defini-
tions of outcomes and methodological quality(24). Compared 
to the review from 2009, the present systematic review re-
flects improvement, because it included all the previously 
analyzed studies, plus three new studies(16-17,22).
Although the objective of all investigations included in 
this review was glycemic control, reduction in morbidity, 
mortality, and SSI indices, there was diversity of treatment 
strategies and glycemic control during the perioperative pe-
riod, and variety of surgeries, and investigated samples. These 
aspects reflect the need for further investigations to decide 
clinically about the best intervention to be applied, since re-
gardless of the method, most studies showed positive results 
when implementing glycemic control to reduce SSI rates.
Among the included studies, seven(15-21) tested the use of 
continuous infusion of insulin compared to different glyce-
mic control methods, and five found that continuous infu-
sion of insulin was superior to other strategies in maintain-
ing blood glucose levels and reducing SSI rates(15-16,18,20-22). 
Only two studies have not demonstrated this association, 
but the control groups tested the bolus infusion of insulin, 
which is also the intravenous infusion of insulin(17,19).
A retrospective study of patients undergoing onco-
logic gynecologic surgeries found that patients undergoing 
strict control of hyperglycemia in the postoperative period 
through intravenous infusion of insulin have developed 
statistically significantly less cases of SSI. This means a re-
duction of 35% compared to diabetic patients with blood 
glucose controlled by subcutaneous insulin(25).
The studies included in this review seem to agree that 
maintaining blood glucose between 80 and 120 mg/dL is as-
sociated with lower rates of complications in the postoperative 
period and hence, lower costs for the hospital(8,10-11,16-19,21-22).
It is noteworthy that less cautious models of glycemic 
control were independently associated to a higher incidence 
of SSI(26). In addition, investigations with different meth-
odological designs seem to agree that maintaining blood 
glucose below 200 mg/dL(25,27), or even below 150 mg/dL(26) 
prevents the occurrence of SSI.
Thus, hyperglycemia is related to difficulties in the pa-
tient recovery process postoperatively, leading to subsequent 
limitations arising from an incomplete or inefficient heal-
ing process. The nursing team performance, particularly of 
nurses, is key for the appropriate preparation and admin-
istration of medication and strict control of blood glucose 
levels. In order to offer the best care, based on the latest sci-
entific evidence, professionals must understand the patho-
physiological process of hyperglycemia(28).
Therefore, data presented in this review suggest the 
importance of tight glycemic control of patients in the 
perioperative period, which benefits their recovery, and the 
continuous infusion of insulin appears to be associated with 
better outcomes.
CONCLUSION
Despite the diversity of tested interventions, studies 
agree that glycemic control is essential to reduce SSI rates 
and should be kept between 80 and 120 mg/dL during the 
perioperative period.
The continuous infusion of intravenous insulin during 
surgery was the most tested, and compared to other strate-
gies, it seems to get better results in reducing SSI rates and 
for the successful glycemic control.
Nursing plays a vital role in the proper implementa-
tion of glycemic control measures, actively participating 
since the measurement of blood glucose until the correct 
and accurate administration of insulin to correct hyper-
glycemia, thus contributing directly to the quality and 
success of the intervention.
However, there should be a more active participation 
of nurses in the development of studies on the theme, by 
taking ownership and developing studies of good method-
ological quality that indicate the most appropriate and suc-
cessful forms for patients’ strict glycemic control, and also 
describing how such interventions demand nursing care.
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RESUMO
Objetivo: Analisar as evidências disponíveis na literatura científica sobre a relação entre as estratégias de controle glicêmico efetuadas 
e a ocorrência de infecção do sítio cirúrgico em pacientes adultos submetidos à cirurgia. Método: Trata-se de revisão sistemática, por 
meio das bases de dados CINAHL, MEDLINE, LILACS, Cochrane Database of Systematic Reviews e EMBASE. Resultados: Foram 
selecionados oito ensaios clínicos randomizados. Apesar da diversidade de intervenções testadas, os estudos concordam que o controle 
glicêmico é essencial para a redução das taxas de infecção do sítio cirúrgico e deve ser mantido entre 80 e 120 mg/dL durante o 
perioperatório. A infusão contínua de insulina no transoperatório foi a mais testada e parece obter melhores resultados na redução das 
taxas de infecção do sítio cirúrgico e sucesso no controle glicêmico comparada às demais estratégias. Conclusão: O controle glicêmico 
rigoroso durante o perioperatório beneficia a recuperação do paciente cirúrgico, destacando-se a atuação da equipe de enfermagem para 
a implantação bem-sucedida da medida.
DESCRITORES
Infecção da Ferida Operatória; Índice Glicêmico; Enfermagem Perioperatória; Revisão.
RESUMEN
Objetivo: Analizar las evidencias disponibles en la literatura científica acerca de la relación entre las estrategias de control glicémico 
realizadas y la ocurrencia de infección del sitio quirúrgico en pacientes adultos sometidos a la cirugía. Método: Se trata de revisión 
sistemática, por medio de las bases de datos CINAHL, MEDLINE, LILACS, Cochrane Database of Systematic Reviews e EMBASE. 
Resultados: Fueron seleccionados ocho ensayos clínicos aleatorizados. A pesar de la diversidad de intervenciones probadas, los estudios 
acuerdan que el control glicémico es esencial para la reducción de las tasas de infección del sitio quirúrgico y se debe mantener entre 80 y 
120 mg/dL durante el perioperatorio. La infusión continua de insulina en el transoperatorio fue la más probada y parece obtener mejores 
resultados en la reducción de las tasas de infección del sitio quirúrgico en el control glicémico comparada con las demás estrategias. 
Conclusión: El control glicémico riguroso durante el perioperatorio beneficia la recuperación del paciente quirúrgico, destacándose la 
actuación del equipo de enfermería para la implantación exitosa de la medida.
DESCRIPTORES
Infección de Herida Operatória; Índice Glucémico; Enfermería Perioperatoria; Revisión.
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